Terry Ferguson

Terry Ferguson serves as the Chief Medical Officer at Cadrenal Therapeutics, Inc. since February 2025, having previously held the same title at Matinas BioPharma from February 2019 to November 2024. Prior to these roles, Terry was an Executive Director at Amgen, overseeing the US Cardiovascular and Bone Therapeutic Areas from August 2016 to February 2019. Terry's extensive experience in the field includes positions at AstraZeneca, where responsibilities included Vice President roles in CV medical and scientific external relations and Global Medical Affairs, as well as Senior Director of Clinical Research. Additionally, Terry served as Vice President of Global Medical at The Medicines Company and held the position of Associate Director of Cardiology Research at Texas Heart Institute for over two decades. Academic credentials include a Medical Doctorate from the University of Pennsylvania School of Medicine and a Bachelor of Arts in Biology from Harvard University.